Literature DB >> 32476813

Is Catheter Ablation Better Than Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation?

Balaji Natarajan1, Srishti Nayak2, Ramdas G Pai1.   

Abstract

Long-standing atrial fibrillation is associated with significant morbidity including stroke and development of heart failure. Patients also report poor quality of life as a result of debilitating symptoms or treatment side effects from antiarrhythmic medications. Radio frequency or cryothermal mediated catheter ablation has a central role in the management of symptomatic patients with paroxysmal or persistent atrial fibrillation. Circumferential pulmonary vein isolation is vital to the success of this therapy and other ancillary techniques have been described, especially for persistent atrial fibrillation. Several randomized controlled studies have been reported over the last two decades studying important clinical outcomes in patients with atrial fibrillation. In this article, we aim to provide a review of the major studies that have helped define the role of catheter ablation in the management of symptomatic atrial fibrillation in patients with both diseased and structurally normal hearts. © Thieme Medical Publishers.

Entities:  

Keywords:  ablation; atrial fibrillation; left atrium; pulmonary vein; radio frequency ablation; stroke; survival

Year:  2020        PMID: 32476813      PMCID: PMC7250632          DOI: 10.1055/s-0039-1700985

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  22 in total

Review 1.  2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  Heart Rhythm       Date:  2019-01-28       Impact factor: 6.343

2.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  J Arrhythm       Date:  2017-09-15

3.  A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

Authors:  Ross J Hunter; Thomas J Berriman; Ihab Diab; Ravindu Kamdar; Laura Richmond; Victoria Baker; Farai Goromonzi; Vinit Sawhney; Edward Duncan; Stephen P Page; Waqas Ullah; Beth Unsworth; Jamil Mayet; Mehul Dhinoja; Mark J Earley; Simon Sporton; Richard J Schilling
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-01

4.  Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.

Authors:  Eric Black-Maier; Xinru Ren; Benjamin A Steinberg; Cynthia L Green; Adam S Barnett; Normita Sta Rosa; Sana M Al-Khatib; Brett D Atwater; James P Daubert; Camille Frazier-Mills; Augustus O Grant; Donald D Hegland; Kevin P Jackson; Larry R Jackson; Jason I Koontz; Robert K Lewis; Albert Y Sun; Kevin L Thomas; Tristam D Bahnson; Jonathan P Piccini
Journal:  Heart Rhythm       Date:  2017-12-06       Impact factor: 6.343

5.  Atrial fibrillation ablation in practice: assessing CABANA generalizability.

Authors:  Peter A Noseworthy; Bernard J Gersh; David M Kent; Jonathan P Piccini; Douglas L Packer; Nilay D Shah; Xiaoxi Yao
Journal:  Eur Heart J       Date:  2019-04-21       Impact factor: 29.983

6.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

Authors:  Jens Cosedis Nielsen; Arne Johannessen; Pekka Raatikainen; Gerhard Hindricks; Håkan Walfridsson; Ole Kongstad; Steen Pehrson; Anders Englund; Juha Hartikainen; Leif Spange Mortensen; Peter Steen Hansen
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

7.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

8.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Authors:  Mohammed N Khan; Pierre Jaïs; Jennifer Cummings; Luigi Di Biase; Prashanthan Sanders; David O Martin; Josef Kautzner; Steven Hao; Sakis Themistoclakis; Raffaele Fanelli; Domenico Potenza; Raimondo Massaro; Oussama Wazni; Robert Schweikert; Walid Saliba; Paul Wang; Amin Al-Ahmad; Salwa Beheiry; Pietro Santarelli; Randall C Starling; Antonio Dello Russo; Gemma Pelargonio; Johannes Brachmann; Volker Schibgilla; Aldo Bonso; Michela Casella; Antonio Raviele; Michel Haïssaguerre; Andrea Natale
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.

Authors:  Pierre Jaïs; Bruno Cauchemez; Laurent Macle; Emile Daoud; Paul Khairy; Rajesh Subbiah; Mélèze Hocini; Fabrice Extramiana; Fréderic Sacher; Pierre Bordachar; George Klein; Rukshen Weerasooriya; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.